Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
about
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsInsights into CYP2B6-mediated drug-drug interactionsDifferent frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive studyEvaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of lifeABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsPopulation pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.Clinical and genetic determinants of nevirapine plasma trough concentration.
P2860
Q28069383-37DAD480-6E6E-4C1F-B3AB-C6CAC0360C69Q28078857-6201E375-5FF7-4AA1-9494-591CEED916E6Q28541365-EB7772D2-B1BB-45A8-843A-B8B85CC98A5BQ35238134-54AAADAC-A3DA-47A2-AAA8-5A8DCD8D1E68Q36370484-2284DCB0-B401-4560-A9D0-8FD399A371A7Q36437792-2110F0EB-F91A-4DA8-9744-080A5F1D76BBQ37544678-CD22D723-781E-42CF-8662-39F36D9425BDQ38051400-A6EA727F-68B5-4ECE-B87B-F62FBC4D1AC3Q38267710-38A2C493-327A-4B9B-80D0-17968B578BE1Q38957969-68D1CDEA-EB73-4E9A-8569-FE9C257D9BAFQ47906608-24DC13E2-AD88-414A-AF08-4FA571E611A3Q49332317-782C2770-CB40-4A38-ACE2-CC46B308E1A9Q55263551-0260652C-3B25-4D5A-B7AA-C5FA8B69B4E1
P2860
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@ast
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@en
type
label
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@ast
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@en
prefLabel
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@ast
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@en
P2093
P2860
P356
P1433
P1476
Exploration of CYP450 and drug ...... virapine exposure in Malawians
@en
P2093
Amanda H Corbett
Angela D M Kashuba
Erin G Schuetz
Howard L McLeod
Hsiao-Chuan Tien
Ida Shumba
Janelle M Hoskins
Jatinder K Lamba
Jean Tauzie
Kevin C Brown
P2860
P304
P356
10.2217/PGS.11.132
P577
2011-11-23T00:00:00Z